Note: Ingredients listed on restricted chemical lists
EC/CAS
231-673-0/7681-57-4
Name of the chemical
Sodium metabisulfite
Concentration
<1
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%<
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
0.5%<
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
>=10%
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
>=0.1%
General Information
Version
2.01
Revision date
2025-10-02
Product name
Procainamide Hydrochloride Injection, USP (Hospira Inc.)
Product name
Procainamide Hydrochloride Injection, USP (Hospira Inc.)
Identification on the label/Trade name
Procainamide Hydrochloride Injection, USP
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical product used as cardiovascular drug
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Hospira, A Pfizer Company
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Procainamide Hydrochloride Pfizer OEL TWA-8 Hr: PBT & vPvB 100 µg/m3, Sensitizer The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
Signal word
Danger
Hazard statements
H317 - May cause an allergic skin reaction H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P284 - In case of inadequate ventilation wear respiratory protection P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor P280 - Wear eye protection/ face protection P321 - Specific treatment (see .? on this label) Unknown acute toxicity 45 - 50 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 45 - 50 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). Unknown aquatic toxicity Contains 45 - 50 % of components with unknown hazards to the aquatic environment.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Respiratory sensitization Category 1 - (H334) Skin sensitization Category 1 - (H317) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
